Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Non-Current Deferred Tax Liability (2019 - 2021)

Historic Non-Current Deferred Tax Liability for SELLAS Life Sciences (SLS) over the last 3 years, with Q4 2021 value amounting to $152000.0.

  • SELLAS Life Sciences' Non-Current Deferred Tax Liability fell 8902.53% to $152000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $152000.0, marking a year-over-year decrease of 8902.53%. This contributed to the annual value of $152000.0 for FY2021, which is 8902.53% down from last year.
  • Per SELLAS Life Sciences' latest filing, its Non-Current Deferred Tax Liability stood at $152000.0 for Q4 2021, which was down 8902.53% from $239000.0 recorded in Q3 2021.
  • In the past 5 years, SELLAS Life Sciences' Non-Current Deferred Tax Liability ranged from a high of $1.4 million in Q4 2020 and a low of $152000.0 during Q4 2021
  • Moreover, its 3-year median value for Non-Current Deferred Tax Liability was $262000.0 (2020), whereas its average is $448166.7.
  • Per our database at Business Quant, SELLAS Life Sciences' Non-Current Deferred Tax Liability soared by 931.33% in 2020 and then plummeted by 8902.53% in 2021.
  • SELLAS Life Sciences' Non-Current Deferred Tax Liability (Quarter) stood at $1.3 million in 2019, then increased by 9.31% to $1.4 million in 2020, then tumbled by 89.03% to $152000.0 in 2021.
  • Its Non-Current Deferred Tax Liability stands at $152000.0 for Q4 2021, versus $239000.0 for Q3 2021 and $239000.0 for Q2 2021.